125 related articles for article (PubMed ID: 38258295)
21. Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma.
Glennie MJ; Brennand DM; Bryden F; McBride HM; Stirpe F; Worth AT; Stevenson GT
J Immunol; 1988 Nov; 141(10):3662-70. PubMed ID: 3141503
[TBL] [Abstract][Full Text] [Related]
22. Saporin from
Bolshakov AP; Stepanichev MY; Dobryakova YV; Spivak YS; Markevich VA
Toxins (Basel); 2020 Aug; 12(9):. PubMed ID: 32854372
[TBL] [Abstract][Full Text] [Related]
23. The crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosome.
Savino C; Federici L; Ippoliti R; Lendaro E; Tsernoglou D
FEBS Lett; 2000 Mar; 470(3):239-43. PubMed ID: 10745075
[TBL] [Abstract][Full Text] [Related]
24. The expression of saporin, a ribosome-inactivating protein from the plant Saponaria officinalis, in Escherichia coli.
Barthelemy I; Martineau D; Ong M; Matsunami R; Ling N; Benatti L; Cavallaro U; Soria M; Lappi DA
J Biol Chem; 1993 Mar; 268(9):6541-8. PubMed ID: 8454624
[TBL] [Abstract][Full Text] [Related]
25. Saporin-S6: a useful tool in cancer therapy.
Polito L; Bortolotti M; Mercatelli D; Battelli MG; Bolognesi A
Toxins (Basel); 2013 Oct; 5(10):1698-722. PubMed ID: 24105401
[TBL] [Abstract][Full Text] [Related]
26. Cholinergic Deficit Induced by Central Administration of 192IgG-Saporin Is Associated With Activation of Microglia and Cell Loss in the Dorsal Hippocampus of Rats.
Dobryakova YV; Volobueva MN; Manolova AO; Medvedeva TM; Kvichansky AA; Gulyaeva NV; Markevich VA; Stepanichev MY; Bolshakov AP
Front Neurosci; 2019; 13():146. PubMed ID: 30930730
[TBL] [Abstract][Full Text] [Related]
27. Saporin as a Commercial Reagent: Its Uses and Unexpected Impacts in the Biological Sciences-Tools from the Plant Kingdom.
Ancheta LR; Shramm PA; Bouajram R; Higgins D; Lappi DA
Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324681
[TBL] [Abstract][Full Text] [Related]
28. Lipid-Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo.
Zhang GN; Gupta P; Wang M; Barbuti AM; Ashby CR; Zhang YK; Zeng L; Xu Q; Fan YF; Chen ZS
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098067
[TBL] [Abstract][Full Text] [Related]
29. Targeting neurokinin-1 receptor-expressing neurons with [Sar9,Met(O2)11 substance P-saporin.
Wiley RG; Lappi DA
Neurosci Lett; 1999 Dec; 277(1):1-4. PubMed ID: 10643883
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Small Molecule Pharmacological Agents on the Triterpenoid Saponin Induced Endolysosomal Escape of Saporin and a Saporin-Based Immunotoxin in Target Human Lymphoma Cells.
Wensley HJ; Smith WS; Holmes SE; Flavell SU; Flavell DJ
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33804080
[TBL] [Abstract][Full Text] [Related]
31. Enhanced cytotoxicity of saporin by polyamidoamine dendrimer conjugation and photochemical internalization.
Lai PS; Pai CL; Peng CL; Shieh MJ; Berg K; Lou PJ
J Biomed Mater Res A; 2008 Oct; 87(1):147-55. PubMed ID: 18085655
[TBL] [Abstract][Full Text] [Related]
32. Augmentation of Saporin-Based Immunotoxins for Human Leukaemia and Lymphoma Cells by Triterpenoid Saponins: The Modifying Effects of Small Molecule Pharmacological Agents.
Smith WS; Johnston DA; Holmes SE; Wensley HJ; Flavell SU; Flavell DJ
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30791598
[TBL] [Abstract][Full Text] [Related]
33. Intracerebroventricular Administration of
Dobryakova YV; Kasianov A; Zaichenko MI; Stepanichev MY; Chesnokova EA; Kolosov PM; Markevich VA; Bolshakov AP
Front Mol Neurosci; 2017; 10():429. PubMed ID: 29386992
[TBL] [Abstract][Full Text] [Related]
34. Saponins from Saponaria officinalis L. Augment the Efficacy of a Rituximab-Immunotoxin.
Gilabert-Oriol R; Thakur M; Haussmann K; Niesler N; Bhargava C; Görick C; Fuchs H; Weng A
Planta Med; 2016 Dec; 82(18):1525-1531. PubMed ID: 27392242
[TBL] [Abstract][Full Text] [Related]
35. Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.
Bostad M; Olsen CE; Peng Q; Berg K; Høgset A; Selbo PK
J Control Release; 2015 May; 206():37-48. PubMed ID: 25758331
[TBL] [Abstract][Full Text] [Related]
36. Triterpenoid saponin augmention of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent.
Holmes SE; Bachran C; Fuchs H; Weng A; Melzig MF; Flavell SU; Flavell DJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):42-55. PubMed ID: 25347443
[TBL] [Abstract][Full Text] [Related]
37. Soapwort saponins trigger clathrin-mediated endocytosis of saporin, a type I ribosome-inactivating protein.
Weng A; Bachran C; Fuchs H; Melzig MF
Chem Biol Interact; 2008 Nov; 176(2-3):204-11. PubMed ID: 18775419
[TBL] [Abstract][Full Text] [Related]
38. Ribosome inactivating protein saporin induces apoptosis through mitochondrial cascade, independent of translation inhibition.
Sikriwal D; Ghosh P; Batra JK
Int J Biochem Cell Biol; 2008; 40(12):2880-8. PubMed ID: 18611444
[TBL] [Abstract][Full Text] [Related]
39. Lipopolyamine treatment increases the efficacy of intoxication with saporin and an anticancer saporin conjugate.
Geden SE; Gardner RA; Fabbrini MS; Ohashi M; Phanstiel Iv O; Teter K
FEBS J; 2007 Sep; 274(18):4825-36. PubMed ID: 17714513
[TBL] [Abstract][Full Text] [Related]
40. Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells.
Yip WL; Weyergang A; Berg K; Tønnesen HH; Selbo PK
Mol Pharm; 2007; 4(2):241-51. PubMed ID: 17263556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
